Results 231 to 240 of about 724,197 (388)
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley +1 more source
True anticoagulation safety cannot be achieved without better anticoagulants. [PDF]
Beavers CJ, Hoffman M.
europepmc +1 more source
Fat Feeding Increases Equine Heparin‐Released Lipoprotein Lipase Activity [PDF]
S.N.J. Geelen +4 more
openalex +1 more source
Heparin fails to inhibit the leukocyte recruitment for an extended time following inflammatory stimulus [PDF]
Dayse Santos Arimatéia +4 more
openalex +1 more source
An in-vitro study of the timing between protamine sulfate administration and cardiotomy suction termination. [PDF]
Gavin-Veyna J +5 more
europepmc +1 more source
Dietary RSO supplementation improved growth performance, simultaneously enriched n‐3 polyunsaturated fatty acids (n‐3 PUFA), and enhanced antioxidant capacity in Pekin ducks, which suggested that RSO has the potential to be a novel n‐3 PUFA source and an antioxidant for Pekin ducks to generate animal functional foods.
Lei Zhuang +10 more
wiley +1 more source
Balancing Bleeding and Clot: Type 2 Heparin-Induced Thrombocytopenia With Extensive Thromboses in a Patient With Subdural Hematoma. [PDF]
Annan GK +4 more
europepmc +1 more source
A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide Fondaparinux [PDF]
Martha Gschwandtner +11 more
openalex +1 more source
Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis
Objective Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in patients with JIA remains elusive.
Viola Pitkänen +13 more
wiley +1 more source

